Not exact matches
When he returned to the United States to take a second postdoc at the Center for
Vaccine Development at the University of Maryland School of Medicine in Baltimore, he also took a second job, teaching microbiology in the
evenings, at nearby Anne Arundel Community College.
Next year, UTMB will start building a high - containment lab that can handle
even the most dangerous viruses — one of only a handful in the U.S. With that capacity, and the expertise concentrated at UTMB, the new center should «make some very important contributions» to
vaccine development, La Montagne predicts.
Even those groups with access to suitable adjuvants frequently fail in the
development of their adjuvanted
vaccines because of a lack of knowledge on how to correctly formulate and characterize both their adjuvants and the resulting
vaccine formulations.
Now, a new
vaccine under
development could deal another blow to the disease, lowering the number of deaths
even further by targeting dozens of additional strains of S. pneumoniae, and anticipating future versions of the bacteria responsible for pneumococcal disease, which includes sepsis and meningitis.